BUDESONIDE

BUDESONIDE was reported 97871 times

These side effects are most commonly reported by patients taking BUDESONIDE:

# Side effect Count
0 DYSPNOEA 6673
1 DRUG INEFFECTIVE 6408
2 OFF LABEL USE 6203
3 ASTHMA 4882
4 FATIGUE 3700
5 COUGH 3367
6 HEADACHE 3283
7 DIARRHOEA 2951
8 CONDITION AGGRAVATED 2893
9 NAUSEA 2846
10 PNEUMONIA 2759
11 WHEEZING 2514
12 MALAISE 2320
13 PAIN 2255
14 PYREXIA 2246
15 WEIGHT DECREASED 2113
16 ARTHRALGIA 1924
17 DIZZINESS 1924
18 PRODUCT USE IN UNAPPROVED INDICATION 1811
19 ABDOMINAL PAIN 1794
20 VOMITING 1782
21 PRODUCT DOSE OMISSION ISSUE 1761
22 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1705
23 HYPERTENSION 1684
24 ASTHENIA 1672
25 RASH 1652
26 WEIGHT INCREASED 1601
27 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1520
28 COLITIS ULCERATIVE 1478
29 CHEST DISCOMFORT 1440
30 CROHN^S DISEASE 1365
31 PRURITUS 1326
32 DEATH 1320
33 PRODUCT USE ISSUE 1318
34 BLOOD PRESSURE INCREASED 1303
35 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1264
36 ANXIETY 1253
37 PAIN IN EXTREMITY 1247
38 INSOMNIA 1226
39 GASTROOESOPHAGEAL REFLUX DISEASE 1221
40 MUSCLE SPASMS 1214
41 PRODUCTIVE COUGH 1184
42 FULL BLOOD COUNT ABNORMAL 1152
43 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1151
44 PERIPHERAL SWELLING 1143
45 COVID-19 1129
46 CONSTIPATION 1109
47 NASOPHARYNGITIS 1100
48 FALL 1085
49 HAEMATOCHEZIA 1080
50 SINUSITIS 1071
51 DRUG HYPERSENSITIVITY 1048
52 BACK PAIN 988
53 ANAEMIA 977
54 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 951
55 ERYTHEMA 930
56 OBSTRUCTIVE AIRWAYS DISORDER 913
57 PULMONARY EMBOLISM 909
58 CHEST PAIN 905
59 TREMOR 903
60 HYPERSENSITIVITY 895
61 FEELING ABNORMAL 887
62 INTENTIONAL PRODUCT MISUSE 883
63 FREQUENT BOWEL MOVEMENTS 875
64 ABDOMINAL PAIN UPPER 857
65 DRUG DOSE OMISSION 851
66 OEDEMA PERIPHERAL 849
67 ABDOMINAL DISCOMFORT 843
68 DECREASED APPETITE 837
69 DEPRESSION 828
70 PALPITATIONS 822
71 INTENTIONAL PRODUCT USE ISSUE 820
72 BRONCHITIS 789
73 LUNG DISORDER 775
74 URTICARIA 772
75 MACULAR DEGENERATION 769
76 URINARY TRACT INFECTION 769
77 HEART RATE INCREASED 767
78 SOMNOLENCE 766
79 DRUG INTERACTION 752
80 NASAL CONGESTION 737
81 DYSPHONIA 725
82 INFLUENZA 724
83 INJECTION SITE PAIN 719
84 RHINORRHOEA 709
85 DRUG INTOLERANCE 705
86 JOINT SWELLING 698
87 HYPOTENSION 694
88 ABDOMINAL DISTENSION 684
89 RECTAL HAEMORRHAGE 682
90 COLITIS 680
91 OROPHARYNGEAL PAIN 680
92 MIGRAINE 678
93 ARTHRITIS 676
94 HOSPITALISATION 676
95 UPPER RESPIRATORY TRACT INFECTION 676
96 INFECTION 659
97 DYSPEPSIA 658
98 MYALGIA 657
99 CONTUSION 654
100 ILLNESS 647
101 INCORRECT DOSE ADMINISTERED 636
102 HYPOXIA 633
103 BRONCHIECTASIS 632
104 DEVICE MALFUNCTION 628
105 CONFUSIONAL STATE 611
106 GENERAL PHYSICAL HEALTH DETERIORATION 604
107 SWELLING FACE 589
108 INFUSION RELATED REACTION 582
109 ACUTE KIDNEY INJURY 579
110 GAIT DISTURBANCE 576
111 STRESS 576
112 THROMBOSIS 571
113 HAEMOPTYSIS 562
114 ALOPECIA 558
115 SEPSIS 557
116 DYSPNOEA EXERTIONAL 553
117 DEHYDRATION 550
118 PULMONARY FIBROSIS 549
119 RENAL FAILURE 543
120 ATRIAL FIBRILLATION 534
121 TACHYCARDIA 531
122 OXYGEN SATURATION DECREASED 520
123 GASTROINTESTINAL DISORDER 508
124 HYPOAESTHESIA 502
125 CHILLS 500
126 PRODUCT QUALITY ISSUE 497
127 RESPIRATORY FAILURE 489
128 SLEEP DISORDER 489
129 PARAESTHESIA 487
130 ACNE 486
131 MUSCULOSKELETAL STIFFNESS 485
132 ADVERSE DRUG REACTION 478
133 HYPOTHYROIDISM 478
134 HYPERHIDROSIS 471
135 SWELLING 469
136 LOWER RESPIRATORY TRACT INFECTION 463
137 BREATH SOUNDS ABNORMAL 456
138 PRESCRIBED UNDERDOSE 456
139 NO ADVERSE EVENT 452
140 DYSGEUSIA 446
141 MUSCULAR WEAKNESS 444
142 CEREBROVASCULAR ACCIDENT 442
143 RESPIRATORY TRACT INFECTION 440
144 VASCULITIS 440
145 IMPAIRED QUALITY OF LIFE 437
146 EOSINOPHILIA 436
147 BLOOD GLUCOSE INCREASED 435
148 DRY MOUTH 434
149 DEVICE ISSUE 431
150 VISION BLURRED 431
151 DIABETES MELLITUS 428
152 CHRONIC SINUSITIS 427
153 BLOOD CREATININE INCREASED 423
154 TREATMENT FAILURE 423
155 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 418
156 DEEP VEIN THROMBOSIS 413
157 ECZEMA 405
158 MYOCARDIAL INFARCTION 402
159 DYSPHAGIA 401
160 MEMORY IMPAIRMENT 401
161 VISUAL IMPAIRMENT 401
162 CARDIAC DISORDER 398
163 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 384
164 HAEMOGLOBIN DECREASED 373
165 RHINITIS ALLERGIC 370
166 FLATULENCE 367
167 ANAPHYLACTIC REACTION 363
168 TINNITUS 361
169 PLEURAL EFFUSION 359
170 NASAL POLYPS 354
171 CATARACT 352
172 INFLAMMATION 352
173 MEDICATION ERROR 348
174 C-REACTIVE PROTEIN INCREASED 347
175 THERAPEUTIC PRODUCT EFFECT DECREASED 347
176 HEPATIC ENZYME INCREASED 342
177 SEIZURE 341
178 LOSS OF CONSCIOUSNESS 340
179 RHEUMATOID ARTHRITIS 340
180 SPUTUM DISCOLOURED 338
181 HAEMORRHAGE 337
182 THROAT IRRITATION 336
183 ALANINE AMINOTRANSFERASE INCREASED 332
184 NODULE 331
185 DUST ALLERGY 330
186 EPISTAXIS 330
187 OEDEMA 330
188 RASH PRURITIC 329
189 ADVERSE EVENT 328
190 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 323
191 EOSINOPHIL COUNT INCREASED 323
192 BLOOD TEST ABNORMAL 322
193 BURNING SENSATION 322
194 PROCEDURAL PAIN 320
195 GASTROINTESTINAL HAEMORRHAGE 318
196 PANCREATITIS 317
197 RESPIRATORY DISTRESS 317
198 MYCOTIC ALLERGY 315
199 ORAL CANDIDIASIS 315
200 SINUS DISORDER 314
201 CONJUNCTIVITIS ALLERGIC 313
202 MITE ALLERGY 313
203 THERAPY NON-RESPONDER 313
204 RENAL IMPAIRMENT 311
205 RESPIRATORY SYMPTOM 311
206 UPPER-AIRWAY COUGH SYNDROME 310
207 VERTIGO 309
208 CHRONIC KIDNEY DISEASE 308
209 NORMOCHROMIC NORMOCYTIC ANAEMIA 308
210 SYNCOPE 308
211 SPIROMETRY ABNORMAL 307
212 DRY SKIN 302
213 ARTERIOSCLEROSIS 301
214 OSTEOPOROSIS 301
215 BLOOD POTASSIUM DECREASED 300
216 BRONCHOSPASM 297
217 MATERNAL EXPOSURE DURING PREGNANCY 295
218 RHINITIS 294
219 RESPIRATORY DISORDER 293
220 BLOOD PRESSURE DECREASED 292
221 SNEEZING 292
222 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 289
223 THERAPEUTIC RESPONSE DECREASED 288
224 ASPARTATE AMINOTRANSFERASE INCREASED 286
225 NEUROPATHY PERIPHERAL 284
226 CUSHINGOID 282
227 HYPOKALAEMIA 282
228 MULTIPLE ALLERGIES 281
229 CARDIAC FAILURE 279
230 INTENTIONAL DEVICE MISUSE 279
231 PULMONARY MASS 279
232 SWOLLEN TONGUE 278
233 PARAESTHESIA ORAL 277
234 SLEEP APNOEA SYNDROME 276
235 CARDIAC MURMUR 274
236 HYPERGLYCAEMIA 274
237 ILL-DEFINED DISORDER 274
238 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 273
239 FLUID RETENTION 273
240 CARDIAC FAILURE CONGESTIVE 271
241 CLOSTRIDIUM DIFFICILE INFECTION 266
242 NEUROLOGICAL SYMPTOM 266
243 ARTHROPATHY 265
244 FLUSHING 265
245 ULCER 264
246 MIDDLE INSOMNIA 263
247 OVERDOSE 263
248 ARTERIOSCLEROSIS CORONARY ARTERY 262
249 FOETAL EXPOSURE DURING PREGNANCY 261
250 DISEASE PROGRESSION 260
251 NERVOUSNESS 260
252 CUSHING^S SYNDROME 258
253 HYPONATRAEMIA 256
254 INTESTINAL OBSTRUCTION 253
255 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 253
256 CELLULITIS 251
257 DISCOMFORT 251
258 DISEASE RECURRENCE 250
259 LACRIMATION INCREASED 250
260 HEART RATE DECREASED 249
261 PLATELET COUNT DECREASED 249
262 HERPES ZOSTER 247
263 THROMBOCYTOPENIA 247
264 TREATMENT NONCOMPLIANCE 247
265 TUBULOINTERSTITIAL NEPHRITIS 245
266 EAR INFECTION 243
267 INCREASED APPETITE 242
268 IRRITABILITY 242
269 INFLUENZA LIKE ILLNESS 241
270 INJECTION SITE ERYTHEMA 241
271 MULTIPLE ORGAN DYSFUNCTION SYNDROME 241
272 TUBERCULOSIS 241
273 PANCYTOPENIA 240
274 PSORIASIS 240
275 TRANSAMINASES INCREASED 240
276 DEVICE USE ISSUE 239
277 PROCTITIS 239
278 PRODUCT DOSE OMISSION 239
279 TRANSIENT ISCHAEMIC ATTACK 239
280 TYPE 2 DIABETES MELLITUS 239
281 VIRAL INFECTION 238
282 EYE PRURITUS 237
283 FORCED EXPIRATORY VOLUME DECREASED 236
284 IMPAIRED WORK ABILITY 236
285 EXPOSURE DURING PREGNANCY 235
286 NIGHTMARE 235
287 AGITATION 234
288 HOT FLUSH 233
289 PULMONARY ALVEOLAR HAEMORRHAGE 232
290 FEELING HOT 231
291 NEUTROPENIA 231
292 COLITIS MICROSCOPIC 228
293 CORONARY ARTERY DISEASE 227
294 WHITE BLOOD CELL COUNT INCREASED 227
295 EMPHYSEMA 225
296 HALLUCINATION 225
297 DRY EYE 224
298 THERAPY INTERRUPTED 223
299 ACCIDENTAL OVERDOSE 222
300 CANDIDA INFECTION 222
301 INJECTION SITE BRUISING 222
302 SKIN EXFOLIATION 222
303 STEROID DEPENDENCE 221
304 ASPIRATION 220
305 FIBROMYALGIA 219
306 LETHARGY 218
307 POLLAKIURIA 218
308 RENAL DISORDER 218
309 END STAGE RENAL DISEASE 217
310 SYSTEMIC LUPUS ERYTHEMATOSUS 216
311 CARDIAC ARREST 215
312 BALANCE DISORDER 214
313 EMOTIONAL DISTRESS 214
314 NEURITIS 214
315 AGGRESSION 213
316 DEVICE FAILURE 213
317 BACTERIAL INFECTION 212
318 INJECTION SITE SWELLING 211
319 PULMONARY VASCULITIS 211
320 RALES 211
321 BLOOD IMMUNOGLOBULIN E INCREASED 209
322 SKIN LESION 206
323 TACHYPNOEA 206
324 WHITE BLOOD CELL COUNT DECREASED 206
325 ADRENAL INSUFFICIENCY 204
326 FEMALE GENITAL TRACT FISTULA 202
327 PRODUCT RESIDUE PRESENT 201
328 BLOOD PRESSURE FLUCTUATION 200
329 PAROSMIA 196
330 NIGHT SWEATS 195
331 BLOOD PRESSURE SYSTOLIC INCREASED 194
332 CHOLELITHIASIS 193
333 FUNGAL INFECTION 193
334 JOINT INJURY 193
335 NECK PAIN 193
336 SURGERY 193
337 PLATELET COUNT INCREASED 192
338 SECRETION DISCHARGE 191
339 GINGIVAL PAIN 190
340 STAPHYLOCOCCAL INFECTION 190
341 PROTEINURIA 189
342 NEPHROLITHIASIS 188
343 RADICULOPATHY 185
344 SEPTIC SHOCK 185
345 STOMATITIS 185
346 DEPRESSED MOOD 183
347 MOBILITY DECREASED 182
348 OSTEOARTHRITIS 182
349 THERAPEUTIC RESPONSE SHORTENED 182
350 ANGIOEDEMA 181
351 BLOOD COUNT ABNORMAL 181
352 LIVER FUNCTION TEST INCREASED 179
353 ARRHYTHMIA 178
354 GRAFT VERSUS HOST DISEASE 178
355 HYPOPNOEA 178
356 VAGINAL DISCHARGE 178
357 CARPAL TUNNEL SYNDROME 177
358 UNEVALUABLE EVENT 175
359 CATARRH 173
360 RED BLOOD CELL SEDIMENTATION RATE INCREASED 173
361 UNDERDOSE 171
362 HYPOACUSIS 170
363 BLOOD CALCIUM INCREASED 169
364 BURNS SECOND DEGREE 169
365 EYE PAIN 169
366 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 169
367 SKIN ULCER 169
368 SEASONAL ALLERGY 168
369 ABDOMINAL PAIN LOWER 167
370 VAGINAL FLATULENCE 167
371 CYTOMEGALOVIRUS INFECTION 166
372 TOXICITY TO VARIOUS AGENTS 165
373 DRUG DOSE OMISSION BY DEVICE 163
374 DEVICE DELIVERY SYSTEM ISSUE 162
375 HEPATITIS 162
376 PULMONARY FUNCTION TEST ABNORMAL 162
377 PRODUCT PRESCRIBING ISSUE 161
378 THROAT TIGHTNESS 161
379 ATELECTASIS 160
380 SPEECH DISORDER 159
381 DIVERTICULITIS 158
382 SYNOVITIS 158
383 OCULAR HYPERAEMIA 157
384 BASAL CELL CARCINOMA 156
385 BONE PAIN 156
386 APHONIA 154
387 BLOOD CHOLESTEROL INCREASED 154
388 THERAPY CESSATION 152
389 ACUTE RESPIRATORY FAILURE 151
390 AMNESIA 151
391 CHEST X-RAY ABNORMAL 151
392 EYE IRRITATION 151
393 GLOMERULAR FILTRATION RATE DECREASED 151
394 INTERSTITIAL LUNG DISEASE 151
395 SUICIDAL IDEATION 151
396 SINUS CONGESTION 150
397 RASH ERYTHEMATOUS 149
398 BLISTER 148
399 CONTRAINDICATED PRODUCT ADMINISTERED 148
400 DRUG DEPENDENCE 148
401 TOTAL LUNG CAPACITY ABNORMAL 148
402 HEART RATE IRREGULAR 147
403 LUNG OPACITY 147
404 PULMONARY OEDEMA 147
405 THERAPEUTIC RESPONSE UNEXPECTED 147
406 MICTURITION URGENCY 146
407 MUSCULOSKELETAL PAIN 146
408 PNEUMOTHORAX 146
409 BENIGN PROSTATIC HYPERPLASIA 145
410 RESTLESSNESS 145
411 BRADYCARDIA 144
412 CYANOSIS 143
413 DEFAECATION URGENCY 143
414 DRUG EFFECT DECREASED 143
415 SKIN DISCOLOURATION 142
416 ANAPHYLACTIC SHOCK 141
417 DIARRHOEA HAEMORRHAGIC 141
418 DRUG ERUPTION 140
419 FAECAL CALPROTECTIN INCREASED 140
420 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 140
421 EAR PRURITUS 139
422 GENERALISED OEDEMA 139
423 INTENTIONAL DRUG MISUSE 139
424 PANCREATITIS ACUTE 139
425 PULMONARY CONGESTION 139
426 BLOOD LACTIC ACID INCREASED 138
427 DISTURBANCE IN ATTENTION 138
428 RASH MACULAR 138
429 RESPIRATORY SYNCYTIAL VIRUS INFECTION 138
430 BLOOD BILIRUBIN INCREASED 137
431 DIALYSIS 137
432 DRUG LEVEL DECREASED 137
433 ELECTROLYTE IMBALANCE 137
434 INJECTION SITE PRURITUS 137
435 RETCHING 137
436 SKIN DISORDER 137
437 INSURANCE ISSUE 136
438 PRODUCT DOSE OMISSION IN ERROR 136
439 PSYCHOMOTOR HYPERACTIVITY 136
440 RHEUMATOID FACTOR POSITIVE 136
441 ACUTE GRAFT VERSUS HOST DISEASE 135
442 BK VIRUS INFECTION 135
443 FEBRILE NEUTROPENIA 135
444 GASTRITIS 135
445 HAEMATEMESIS 135
446 HYPERCHOLESTEROLAEMIA 135
447 NEOPLASM MALIGNANT 135
448 PNEUMONITIS 135
449 PSEUDOMONAS INFECTION 135
450 TOTAL LUNG CAPACITY DECREASED 135
451 BRONCHIAL SECRETION RETENTION 134
452 NEURALGIA 134
453 RESPIRATORY TRACT CONGESTION 134
454 ADENOVIRUS INFECTION 133
455 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 133
456 CRYING 133
457 RIB FRACTURE 133
458 EAR PAIN 132
459 FEELING COLD 132
460 CONGENITAL HIATUS HERNIA 131
461 INCREASED TENDENCY TO BRUISE 131
462 LIVER DISORDER 131
463 POLYP 131
464 SKIN NECROSIS 131
465 SMALL INTESTINAL OBSTRUCTION 131
466 GASTROENTERITIS VIRAL 130
467 HEPATIC FAILURE 130
468 HIATUS HERNIA 130
469 ACCIDENTAL EXPOSURE TO PRODUCT 129
470 PALLOR 129
471 BLOOD PRESSURE ABNORMAL 128
472 CHOKING 128
473 DYSURIA 128
474 LIP SWELLING 128
475 LUNG INFECTION 128
476 ASTHMATIC CRISIS 127
477 EYE DISORDER 127
478 FACE OEDEMA 127
479 LUNG NEOPLASM MALIGNANT 127
480 SENSITISATION 127
481 AGEUSIA 126
482 EYE SWELLING 126
483 HYPERCALCAEMIA 126
484 INCORRECT DOSE ADMINISTERED BY DEVICE 126
485 PRODUCT PRESCRIBING ERROR 126
486 ANOSMIA 125
487 COAGULOPATHY 124
488 GLAUCOMA 124
489 HYPOGAMMAGLOBULINAEMIA 124
490 POLYCYSTIC OVARIES 124
491 INJECTION SITE HAEMORRHAGE 122
492 INTENTIONAL DOSE OMISSION 122
493 PLEURITIC PAIN 122
494 LYMPHADENOPATHY 121
495 APHTHOUS ULCER 120
496 BODY HEIGHT DECREASED 120
497 DRUG SPECIFIC ANTIBODY PRESENT 120
498 DRUG-INDUCED LIVER INJURY 120
499 CYTOMEGALOVIRUS INFECTION REACTIVATION 119
500 GOUT 119
501 INJURY 119
502 WRONG TECHNIQUE IN DRUG USAGE PROCESS 119
503 BLOOD URINE PRESENT 118
504 INJECTION SITE REACTION 118
505 ANAL FISSURE 117
506 HUNGER 117
507 PANIC ATTACK 117
508 BODY TEMPERATURE DECREASED 116
509 DEPRESSED LEVEL OF CONSCIOUSNESS 116
510 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 116
511 LEUKOPENIA 116
512 MOOD ALTERED 116
513 ASPERGILLUS INFECTION 115
514 DEAFNESS 115
515 LIMB INJURY 115
516 MENTAL DISORDER 115
517 PRODUCT STORAGE ERROR 114
518 CYSTITIS 113
519 LABORATORY TEST ABNORMAL 113
520 DISORIENTATION 112
521 DRUG ADMINISTRATION ERROR 112
522 IRON DEFICIENCY ANAEMIA 112
523 HAEMORRHOIDS 111
524 MOUTH ULCERATION 111
525 MYELOSUPPRESSION 111
526 COGNITIVE DISORDER 110
527 CONVULSION 110
528 FAECES DISCOLOURED 110
529 LIMB DISCOMFORT 110
530 POOR QUALITY SLEEP 110
531 RED BLOOD CELL COUNT DECREASED 110
532 HAEMATURIA 109
533 INFUSION SITE PAIN 109
534 PANNICULITIS 109
535 PHARYNGITIS STREPTOCOCCAL 109
536 CHROMATURIA 108
537 DERMATITIS 108
538 DRUG LEVEL BELOW THERAPEUTIC 108
539 ENDOMETRIOSIS 108
540 FEELING JITTERY 108
541 PRODUCT ADMINISTRATION ERROR 108
542 RHEUMATOID NODULE 108
543 ABNORMAL BEHAVIOUR 107
544 ALCOHOL POISONING 107
545 CLOSTRIDIUM DIFFICILE COLITIS 107
546 EJECTION FRACTION 107
547 HEPATOTOXICITY 107
548 LIQUID PRODUCT PHYSICAL ISSUE 107
549 MUCOUS STOOLS 107
550 HEAD DISCOMFORT 106
551 THERAPEUTIC REACTION TIME DECREASED 106
552 URINARY INCONTINENCE 106
553 BLOOD PARATHYROID HORMONE DECREASED 105
554 CROHN'S DISEASE 105
555 LEUKOCYTOSIS 105
556 PULMONARY HYPERTENSION 105
557 RENAL FAILURE ACUTE 105
558 THROAT CLEARING 105
559 BLOOD IRON DECREASED 104
560 BRONCHOPULMONARY ASPERGILLOSIS 104
561 GASTROINTESTINAL INFLAMMATION 104
562 INFLAMMATORY BOWEL DISEASE 104
563 MOOD SWINGS 104
564 NEUTROPHILIA 104
565 ANGINA PECTORIS 103
566 DRUG EXPOSURE DURING PREGNANCY 103
567 HYPERKALAEMIA 103
568 PHOTOSENSITIVITY REACTION 103
569 MALNUTRITION 102
570 POOR VENOUS ACCESS 102
571 WEIGHT FLUCTUATION 102
572 GRANULOMA SKIN 101
573 HYPERLIPIDAEMIA 101
574 HYPOALBUMINAEMIA 101
575 LARYNGEAL STENOSIS 101
576 BRAIN FOG 100
577 IMPAIRED HEALING 100
578 MELAENA 99
579 OSTEONECROSIS 99
580 PNEUMONIA ASPIRATION 99
581 PRESYNCOPE 99
582 HYPOGLYCAEMIA 98
583 HYPOPHAGIA 98
584 ORAL PAIN 98
585 PRODUCT TASTE ABNORMAL 98
586 URINARY RETENTION 98
587 APHASIA 97
588 GASTRIC DISORDER 97
589 ILEAL STENOSIS 97
590 NASAL OBSTRUCTION 97
591 PERICARDIAL EFFUSION 97
592 PREMATURE BABY 97
593 THIRST 97
594 ANAL INCONTINENCE 96
595 CONJUNCTIVITIS 96
596 FISTULA 96
597 IRRITABLE BOWEL SYNDROME 96
598 LOCALISED INFECTION 96
599 BLOOD ALKALINE PHOSPHATASE INCREASED 95
600 BODY TEMPERATURE INCREASED 95
601 HAEMATOCRIT DECREASED 95
602 HAEMATOMA 95
603 MUSCULOSKELETAL CHEST PAIN 95
604 BLOOD SODIUM DECREASED 94
605 POST PROCEDURAL COMPLICATION 94
606 DYSKINESIA 93
607 ABSCESS 92
608 DEVICE DEFECTIVE 92
609 PHARYNGITIS 92
610 SPINAL FRACTURE 92
611 WOUND 92
612 DRY THROAT 91
613 HIP FRACTURE 91
614 OROPHARYNGEAL DISCOMFORT 91
615 LARYNGITIS 90
616 NEPHROPATHY TOXIC 90
617 PRODUCT AVAILABILITY ISSUE 90
618 RESPIRATION ABNORMAL 90
619 DERMATITIS CONTACT 89
620 INCREASED UPPER AIRWAY SECRETION 89
621 LIVER FUNCTION TEST ABNORMAL 89
622 PHARMACEUTICAL PRODUCT COMPLAINT 89
623 SINUS TACHYCARDIA 89
624 ACUTE HEPATIC FAILURE 88
625 GRAFT VERSUS HOST DISEASE IN SKIN 88
626 MALIGNANT NEOPLASM PROGRESSION 88
627 RASH PAPULAR 88
628 GAIT INABILITY 87
629 GAMMA-GLUTAMYLTRANSFERASE INCREASED 87
630 HEAD INJURY 87
631 ROAD TRAFFIC ACCIDENT 87
632 BOWEL MOVEMENT IRREGULARITY 86
633 OBSTRUCTIVE SLEEP APNOEA SYNDROME 86
634 PROCTALGIA 86
635 PRODUCT SUBSTITUTION ISSUE 86
636 PSYCHOTIC DISORDER 86
637 SCOLIOSIS 86
638 UVEITIS 86
639 DYSARTHRIA 85
640 HERNIA 85
641 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 85
642 NERVOUS SYSTEM DISORDER 85
643 PAIN IN JAW 85
644 REVERSIBLE AIRWAYS OBSTRUCTION 85
645 RHABDOMYOLYSIS 85
646 EOSINOPHILIC OESOPHAGITIS 84
647 INTERNATIONAL NORMALISED RATIO INCREASED 84
648 ASCITES 83
649 BLOOD CREATINE PHOSPHOKINASE INCREASED 83
650 BLOOD POTASSIUM INCREASED 83
651 OSTEOPENIA 83
652 SINUS OPERATION 83
653 ABNORMAL LOSS OF WEIGHT 82
654 DRUG SPECIFIC ANTIBODY 82
655 IRON DEFICIENCY 82
656 LYMPHOCYTE COUNT DECREASED 82
657 THERAPY PARTIAL RESPONDER 82
658 VOCAL CORD DYSFUNCTION 82
659 ANGER 81
660 EXPOSURE VIA SKIN CONTACT 81
661 HYPERSOMNIA 81
662 HYPOVOLAEMIA 81
663 SKIN LACERATION 81
664 DRUG TOLERANCE DECREASED 80
665 ABORTION SPONTANEOUS 79
666 C-REACTIVE PROTEIN ABNORMAL 79
667 COMA 79
668 CYSTITIS HAEMORRHAGIC 79
669 DRUG EFFECT INCOMPLETE 79
670 ENCEPHALOPATHY 79
671 ENERGY INCREASED 79
672 ENTERITIS 79
673 MUSCULOSKELETAL DISCOMFORT 79
674 ORAL HERPES 79
675 FOOT FRACTURE 78
676 MENTAL STATUS CHANGES 78
677 TASTE DISORDER 78
678 UNRESPONSIVE TO STIMULI 78
679 BLINDNESS 77
680 BLOOD UREA INCREASED 77
681 CIRCULATORY COLLAPSE 77
682 DEMENTIA 77
683 DRUG LEVEL ABOVE THERAPEUTIC 77
684 FRUSTRATION TOLERANCE DECREASED 77
685 NEUTROPHIL COUNT DECREASED 77
686 APPENDICITIS 76
687 ASPHYXIA 76
688 CARDIOVASCULAR DISORDER 76
689 CEREBRAL HAEMORRHAGE 76
690 DELIRIUM 76
691 DRUG PRESCRIBING ERROR 76
692 DRUG RESISTANCE 76
693 GASTROENTERITIS 76
694 KIDNEY INFECTION 76
695 SKIN ATROPHY 76
696 TOOTHACHE 76
697 CYSTIC FIBROSIS 75
698 MENTAL IMPAIRMENT 75
699 MOVEMENT DISORDER 75
700 PROSTATE CANCER 75
701 TOOTH DISORDER 75
702 UPPER LIMB FRACTURE 75
703 EOSINOPHILIC BRONCHITIS 74
704 HYPOMAGNESAEMIA 74
705 INFUSION SITE ERYTHEMA 74
706 MUCOSAL INFLAMMATION 74
707 NOCTURIA 74
708 FLANK PAIN 73
709 GASTROINTESTINAL INFECTION 73
710 INFUSION SITE SWELLING 73
711 INTERVERTEBRAL DISC PROTRUSION 73
712 METABOLIC ACIDOSIS 73
713 RESPIRATORY RATE INCREASED 73
714 RHINOVIRUS INFECTION 73
715 SKIN STRIAE 73
716 EATING DISORDER 72
717 EMOTIONAL DISORDER 72
718 FAECES SOFT 72
719 IMMUNOSUPPRESSION 72
720 MYASTHENIA GRAVIS 72
721 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 71
722 ENCEPHALITIS CYTOMEGALOVIRUS 71
723 EXTRA DOSE ADMINISTERED 71
724 GLOSSODYNIA 71
725 HEPATIC STEATOSIS 71
726 NEUTROPHIL COUNT INCREASED 71
727 PREGNANCY 71
728 ACUTE MYOCARDIAL INFARCTION 70
729 BREAST CANCER 70
730 BRONCHIOLITIS 70
731 COLD SWEAT 70
732 DYSSTASIA 70
733 EPSTEIN-BARR VIRAEMIA 70
734 LACTIC ACIDOSIS 70
735 RESTLESS LEGS SYNDROME 70
736 UPPER GASTROINTESTINAL HAEMORRHAGE 70
737 VISUAL ACUITY REDUCED 70
738 CAPILLARITIS 69
739 FEEDING DISORDER 69
740 LABILE BLOOD PRESSURE 69
741 PHARYNGEAL SWELLING 69
742 SUPERINFECTION 69
743 BLOOD GLUCOSE DECREASED 68
744 DIPLOPIA 68
745 GROWTH FAILURE 68
746 INTESTINAL PERFORATION 68
747 JOINT STIFFNESS 68
748 MYOPATHY 68
749 NEPHROPATHY 68
750 ADRENAL SUPPRESSION 67
751 BACTERAEMIA 67
752 BACTERIAL DISEASE CARRIER 67
753 CARDIO-RESPIRATORY ARREST 67
754 FEAR 67
755 HYPOPHOSPHATAEMIA 67
756 IMMUNE SYSTEM DISORDER 67
757 QUALITY OF LIFE DECREASED 67
758 INTESTINAL STENOSIS 66
759 LOSS OF THERAPEUTIC RESPONSE 66
760 MUSCLE ATROPHY 66
761 PULMONARY FUNCTION TEST DECREASED 66
762 COVID-19 PNEUMONIA 65
763 DEVICE RELATED INFECTION 65
764 FOOD ALLERGY 65
765 HYPOCALCAEMIA 65
766 INJECTION SITE RASH 65
767 POST PROCEDURAL HAEMORRHAGE 65
768 SARCOIDOSIS 65
769 EJECTION FRACTION ABNORMAL 64
770 GLYCOSYLATED HAEMOGLOBIN INCREASED 64
771 HYPERTENSIVE CRISIS 64
772 IMMUNODEFICIENCY 64
773 INJECTION SITE MASS 64
774 MALIGNANT MELANOMA IN SITU 64
775 MULTIPLE SCLEROSIS 64
776 RASH GENERALISED 64
777 RASH MACULO-PAPULAR 64
778 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 63
779 GASTROINTESTINAL WALL THICKENING 63
780 NASAL DISCOMFORT 63
781 OBESITY 63
782 INITIAL INSOMNIA 62
783 MITRAL VALVE INCOMPETENCE 62
784 RESPIRATORY ARREST 62
785 SHOCK 62
786 SYMPTOM RECURRENCE 62
787 TROPONIN INCREASED 62
788 CARDIOMEGALY 61
789 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 61
790 FEMUR FRACTURE 61
791 INABILITY TO AFFORD MEDICATION 61
792 LARGE INTESTINE POLYP 61
793 NEPHRECTOMY 61
794 ORTHOSTATIC HYPOTENSION 61
795 PRODUCT USE COMPLAINT 61
796 STENOTROPHOMONAS INFECTION 61
797 SUPRAVENTRICULAR TACHYCARDIA 61
798 TOOTH INFECTION 61
799 WITHDRAWAL SYNDROME 61
800 BLOOD PRESSURE DIASTOLIC DECREASED 60
801 COLECTOMY 60
802 DRUG EFFECT LESS THAN EXPECTED 60
803 MALIGNANT MELANOMA STAGE 0 60
804 THROMBOTIC MICROANGIOPATHY 60
805 THYROID DISORDER 60
806 ANKLE FRACTURE 59
807 EPILEPSY 59
808 PNEUMOCYSTIS JIROVECII PNEUMONIA 59
809 PRURITUS GENERALISED 59
810 RENAL PAIN 59
811 SKIN BURNING SENSATION 59
812 BLOOD MAGNESIUM DECREASED 58
813 DIVERTICULUM 58
814 ELECTROCARDIOGRAM QT PROLONGED 58
815 GASTROINTESTINAL PAIN 58
816 HEPATORENAL SYNDROME 58
817 IMPAIRED GASTRIC EMPTYING 58
818 INFLAMMATORY MARKER INCREASED 58
819 MALIGNANT MELANOMA 58
820 NEUROLEPTIC MALIGNANT SYNDROME 58
821 PNEUMONIA BACTERIAL 58
822 TENDERNESS 58
823 ABDOMINAL TENDERNESS 57
824 ERYTHEMA NODOSUM 57
825 HEPATIC FUNCTION ABNORMAL 57
826 HIRSUTISM 57
827 INCORRECT ROUTE OF DRUG ADMINISTRATION 57
828 INJECTION SITE URTICARIA 57
829 PNEUMONIA FUNGAL 57
830 DERMATITIS ALLERGIC 56
831 GASTRIC ULCER 56
832 HYPERPHOSPHATAEMIA 56
833 INFUSION SITE EXTRAVASATION 56
834 OBSTRUCTION 56
835 PROTEIN URINE PRESENT 56
836 SINUSITIS FUNGAL 56
837 SKIN IRRITATION 56
838 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 56
839 ANAL FISTULA 55
840 AUTOIMMUNE DISORDER 55
841 COAGULATION FACTOR DEFICIENCY 55
842 COELIAC DISEASE 55
843 DERMATITIS ATOPIC 55
844 DRUG LEVEL INCREASED 55
845 EXPIRED PRODUCT ADMINISTERED 55
846 HEPATIC ENCEPHALOPATHY 55
847 JAUNDICE CHOLESTATIC 55
848 ORAL DISCOMFORT 55
849 PARANASAL SINUS DISCOMFORT 55
850 PHOTOPHOBIA 55
851 RENAL INJURY 55
852 RESPIRATORY TRACT INFECTION VIRAL 55
853 SKIN CANCER 55
854 SKIN INFECTION 55
855 STEVENS-JOHNSON SYNDROME 55
856 VITAMIN D DECREASED 55
857 ABNORMAL DREAMS 54
858 ABNORMAL FAECES 54
859 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 54
860 BONE DENSITY DECREASED 54
861 ERECTILE DYSFUNCTION 54
862 EYE INFECTION 54
863 FACIAL PAIN 54
864 HEPATOCELLULAR INJURY 54
865 ILEUS 54
866 KNEE ARTHROPLASTY 54
867 LOWER LIMB FRACTURE 54
868 OESOPHAGITIS 54
869 SENSITIVITY TO WEATHER CHANGE 54
870 URINE ABNORMALITY 54
871 ADVERSE REACTION 53
872 ANAL ABSCESS 53
873 CEREBRAL INFARCTION 53
874 INCONTINENCE 53
875 INCREASED BRONCHIAL SECRETION 53
876 NASAL DRYNESS 53
877 PERIPHERAL COLDNESS 53
878 TOXIC EPIDERMAL NECROLYSIS 53
879 VITAMIN D DEFICIENCY 53
880 ABSCESS INTESTINAL 52
881 ACUTE RESPIRATORY DISTRESS SYNDROME 52
882 CHOLECYSTITIS 52
883 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 52
884 EAR DISCOMFORT 52
885 GROWTH RETARDATION 52
886 PHARYNGEAL OEDEMA 52
887 PNEUMONIA VIRAL 52
888 PRESCRIBED OVERDOSE 52
889 SCIATICA 52
890 ABDOMINAL ABSCESS 51
891 DECREASED ACTIVITY 51
892 DIZZINESS POSTURAL 51
893 FACTOR V LEIDEN MUTATION 51
894 HAIR GROWTH ABNORMAL 51
895 ORTHOPNOEA 51
896 SCHIZOPHRENIA 51
897 TENDONITIS 51
898 TRICUSPID VALVE INCOMPETENCE 51
899 ACTIVITIES OF DAILY LIVING IMPAIRED 50
900 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 50
901 ANHEDONIA 50
902 BLOOD ALBUMIN DECREASED 50
903 EYE HAEMORRHAGE 50
904 HYPOAESTHESIA ORAL 50
905 MUSCLE TIGHTNESS 50
906 MUSCLE TWITCHING 50
907 NEEDLE ISSUE 50
908 PETECHIAE 50
909 SHOCK HAEMORRHAGIC 50
910 SPUTUM CULTURE POSITIVE 50
911 VAGINAL HAEMORRHAGE 50
912 VITAL CAPACITY DECREASED 50
913 CHOLESTASIS 49
914 DUODENAL ULCER 49
915 EXERCISE TOLERANCE DECREASED 49
916 FRACTURE 49
917 HEPATIC CIRRHOSIS 49
918 LARGE INTESTINAL ULCER 49
919 MULTI-ORGAN FAILURE 49
920 PARALYSIS 49
921 RHONCHI 49
922 TOTAL LUNG CAPACITY INCREASED 49
923 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 48
924 CYST 48
925 EJECTION FRACTION DECREASED 48
926 HAEMORRHAGIC DIATHESIS 48
927 HYPERTENSIVE URGENCY 48
928 INTRAOCULAR PRESSURE INCREASED 48
929 JAUNDICE 48
930 LIGAMENT SPRAIN 48
931 SEROTONIN SYNDROME 48
932 THINKING ABNORMAL 48
933 ACQUIRED FACTOR V DEFICIENCY 47
934 BURSITIS 47
935 CYTOMEGALOVIRUS COLITIS 47
936 ERUCTATION 47
937 HYPOKINESIA 47
938 HYSTERECTOMY 47
939 LOWER GASTROINTESTINAL HAEMORRHAGE 47
940 OSTEOMYELITIS 47
941 ROTATOR CUFF SYNDROME 47
942 SPINAL OSTEOARTHRITIS 47
943 STAPHYLOCOCCAL SEPSIS 47
944 TENDON RUPTURE 47
945 ECONOMIC PROBLEM 46
946 EPSTEIN-BARR VIRUS INFECTION 46
947 LUNG INFILTRATION 46
948 PERIORBITAL OEDEMA 46
949 PHARYNGOLARYNGEAL PAIN 46
950 PRODUCT PACKAGING QUANTITY ISSUE 46
951 PRODUCT SUPPLY ISSUE 46
952 ARTHROPOD BITE 45
953 CANDIDIASIS 45
954 CARDIOGENIC SHOCK 45
955 DEVICE LEAKAGE 45
956 FOREIGN BODY SENSATION IN EYES 45
957 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 45
958 MASS 45
959 REBOUND EFFECT 45
960 SCAB 45
961 SCAR 45
962 SENSATION OF FOREIGN BODY 45
963 SENSORY DISTURBANCE 45
964 SPUTUM INCREASED 45
965 ALLERGIC GRANULOMATOUS ANGIITIS 44
966 ANGIOPATHY 44
967 AUTOIMMUNE HEPATITIS 44
968 BLOOD CALCIUM DECREASED 44
969 DISSEMINATED INTRAVASCULAR COAGULATION 44
970 DRUG DELIVERY SYSTEM ISSUE 44
971 EYE INFLAMMATION 44
972 HEMIPARESIS 44
973 HYPERTHYROIDISM 44
974 HYPOMANIA 44
975 INTENTIONAL UNDERDOSE 44
976 SMALL FOR DATES BABY 44
977 SQUAMOUS CELL CARCINOMA 44
978 UMBILICAL HERNIA 44
979 FLUID OVERLOAD 43
980 HAEMOGLOBIN ABNORMAL 43
981 HYPERAESTHESIA TEETH 43
982 INFECTION SUSCEPTIBILITY INCREASED 43
983 OLIGURIA 43
984 PAIN OF SKIN 43
985 PRODUCT DISTRIBUTION ISSUE 43
986 PRODUCT PHYSICAL ISSUE 43
987 SCRATCH 43
988 VARICELLA ZOSTER VIRUS INFECTION 43
989 ABDOMINAL ADHESIONS 42
990 ANALGESIC THERAPY 42
991 AORTIC STENOSIS 42
992 BLOOD LACTATE DEHYDROGENASE INCREASED 42
993 BLOOD URIC ACID INCREASED 42
994 CONCUSSION 42
995 DECUBITUS ULCER 42
996 GALLBLADDER DISORDER 42
997 HEART RATE ABNORMAL 42
998 HEPATOMEGALY 42
999 HERPES VIRUS INFECTION 42